Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis

PHASE2CompletedINTERVENTIONAL

Enrollment

320

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Proctitis

Interventions

DRUG

Budesonide 2 mg suppository

per day

DRUG

Budesonide 4 mg suppository

per day

DRUG

Mesalazine 1 g suppository

per day

DRUG

Budesonide 2 mg suppository/Mesalazine 1 g suppository

per day

Trial Locations (2)

Charité-Campus Benjamin Franklin Universitätsmedizin Berlin, Berlin

Evang. Krankenhaus Kalk, Medical Department, Cologne